Australia's biotech firm Biotron rises on Sedarex acquisition

Biotron

15/10/2025 03:23

** Shares of Biotron BIT.AX rise as much as 42.9% to A$0.005, hitting their highest level since August 14

** Stock logs its highest intraday pct gain since August 13

** The biotech firm acquires Sedarex, an unlisted company which holds global patents for SedRx - a next-gen general anaesthetic

** Co says deal for A$1.5 million ($9,75,750.00), among others

** Under deal, co raising A$1 million through placement at issue price of A$0.003 apiece

** Stock down 68.3% this year, including the day's move

($1 = 1.5373 Australian dollars)

 (Reporting by Rajasik Mukherjee in Bengaluru)

 ((Rajasik.Mukherjee@thomsonreuters.com))